HK Stock MarketDetailed Quotes

06185 CANSINOBIO

Watchlist

30.300
-0.050-0.16%

Trading Dec 23 10:35 CST

7.50BMarket Cap-9.39P/E (TTM)

CANSINOBIO Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Turnover

222.88%567.08M

1,253.60%285.42M

13.65%114.28M

-66.52%345.18M

-75.17%175.63M

-96.65%21.09M

-79.86%100.55M

-76.02%1.03B

-77.08%707.4M

-69.45%629.79M

Operating income

222.88%567.08M

1,253.60%285.42M

13.65%114.28M

-66.52%345.18M

-75.17%175.63M

-96.65%21.09M

-79.86%100.55M

-76.02%1.03B

-77.08%707.4M

-69.45%629.79M

Cost of sales

----

87.68%-98.27M

----

-0.29%-1.22B

----

-154.31%-797.57M

----

6.17%-1.22B

----

49.85%-313.62M

Operating expenses

15.30%-146.28M

87.68%-98.27M

29.08%-46.23M

-0.29%-1.22B

28.54%-172.72M

-154.31%-797.57M

56.10%-65.19M

6.17%-1.22B

76.91%-241.69M

49.85%-313.62M

Gross profit

14,344.25%420.79M

124.10%187.15M

92.41%68.05M

-369.45%-876.02M

-99.37%2.91M

-345.59%-776.49M

-89.92%35.37M

-106.22%-186.61M

-77.16%465.71M

-77.98%316.17M

Selling expenses

-1.24%-196.04M

12.70%-112.48M

15.27%-46.59M

-32.55%-353.4M

-29.84%-193.63M

-44.93%-128.84M

-60.25%-54.98M

-151.95%-266.61M

-132.61%-149.14M

-157.07%-88.9M

Administrative expenses

37.57%-117.43M

37.33%-87.78M

38.78%-37.07M

-5.89%-294.45M

11.11%-188.09M

-0.30%-140.05M

5.54%-60.55M

-19.95%-278.07M

-49.97%-211.61M

-54.35%-139.63M

Research and development expenses

41.02%-272.27M

45.06%-185.9M

35.40%-96.75M

18.02%-637.99M

15.92%-461.67M

-4.45%-338.37M

4.70%-149.77M

11.43%-778.26M

16.27%-549.07M

41.23%-323.97M

Profit from asset sales

-163.08%-23.63K

----

--37.46K

----

Revaluation surplus

53.23%-7.19M

----

-129.16%-2.09M

----

-379.50%-15.37M

----

56.11%7.17M

----

-82.25%5.5M

----

-Changes in the fair value of other assets

53.23%-7.19M

----

-129.16%-2.09M

----

-379.50%-15.37M

----

56.11%7.17M

----

-82.25%5.5M

----

Impairment and provision

97.02%-23.9M

30.59%-14.06M

-16.94%-15.05M

-71.43%-15.05M

-50.46%-801.12M

-338.13%-20.26M

-108.88%-12.87M

-381.20%-8.78M

-11,281.90%-532.45M

-6,148.65%-4.62M

-Other impairment is provision

97.02%-23.9M

30.59%-14.06M

-16.94%-15.05M

-71.43%-15.05M

-50.46%-801.12M

-338.13%-20.26M

-108.88%-12.87M

-381.20%-8.78M

-11,281.90%-532.45M

-6,148.65%-4.62M

Special items of operating profit

-113.76%-23.02M

-160.73%-37.4M

-230.88%-66.79M

-5.26%141.72M

44.00%167.28M

-19.13%61.58M

31.82%51.03M

16.99%149.58M

204.12%116.16M

78.83%76.15M

Operating profit

84.89%-225.94M

81.34%-250.47M

-6.28%-198.26M

-48.69%-2.04B

-73.96%-1.5B

-714.58%-1.34B

-242.43%-186.54M

-171.60%-1.37B

-169.67%-859.78M

-120.54%-164.8M

Financing income

----

-38.87%54.09M

----

-46.75%120.64M

----

-36.10%88.49M

----

184.45%226.57M

----

235.72%138.49M

Financing cost

-96.12%3.11M

-11.65%-32.82M

502.46%23.38M

-53.82%-64.34M

-62.52%80.29M

-92.87%-29.4M

36.14%-5.81M

23.21%-41.83M

250.27%214.19M

-125.86%-15.24M

Special items of earning before tax

92.94%-2.87M

----

99.98%-1.72K

----

-3,128.89%-40.7M

----

-729.24%-8.12M

----

74.07%-1.26M

----

Earning before tax

84.50%-225.7M

82.14%-229.2M

12.76%-174.88M

-67.14%-1.98B

-125.10%-1.46B

-2,988.28%-1.28B

-265.82%-200.47M

-161.13%-1.18B

-150.13%-646.85M

-104.97%-41.56M

Tax

-228.18%-1.49M

-182.82%-964K

----

-94.78%11.45M

-99.26%1.16M

-97.98%1.16M

558.58%30.27M

838.17%219.24M

263.56%158.17M

-42.57%57.6M

After-tax profit from continuing operations

84.38%-227.2M

82.05%-230.16M

-2.75%-174.88M

-103.93%-1.97B

-197.72%-1.45B

-8,092.09%-1.28B

-248.91%-170.2M

-150.59%-964.76M

-136.64%-488.68M

-98.29%16.04M

Earning after tax

84.38%-227.2M

82.05%-230.16M

-2.75%-174.88M

-103.93%-1.97B

-197.72%-1.45B

-8,092.09%-1.28B

-248.91%-170.2M

-150.59%-964.76M

-136.64%-488.68M

-98.29%16.04M

Minority profit

98.98%-4.79M

98.91%-4.79M

84.38%-4.79M

-776.08%-484.7M

-3,192.65%-469.89M

-11,683.23%-440.74M

-330.62%-30.65M

-657.48%-55.33M

---14.27M

--3.81M

Profit attributable to shareholders

77.42%-222.41M

73.22%-225.37M

-21.89%-170.1M

-63.04%-1.48B

-107.63%-985.03M

-6,975.54%-841.43M

-214.94%-139.55M

-147.51%-909.43M

-135.57%-474.41M

-98.69%12.24M

Basic earnings per share

77.44%-0.9

73.31%-0.91

-21.05%-0.69

-63.32%-6.01

-107.81%-3.99

-6,988.89%-3.41

-216.33%-0.57

-147.55%-3.68

-135.62%-1.92

-98.69%0.0495

Diluted earnings per share

77.44%-0.9

73.31%-0.91

-21.05%-0.69

-63.32%-6.01

-107.81%-3.99

-6,988.89%-3.41

-216.33%-0.57

-147.55%-3.68

-135.62%-1.92

-98.69%0.0495

Currency Unit

CNY

Accounting Standards

CAS (2007)

HKAS

CAS (2007)

HKAS

CAS (2007)

HKAS

CAS (2007)

HKAS

CAS (2007)

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Turnover	222.88%567.08M	1,253.60%285.42M	13.65%114.28M	-66.52%345.18M	-75.17%175.63M	-96.65%21.09M	-79.86%100.55M	-76.02%1.03B	-77.08%707.4M	-69.45%629.79M
Operating income	222.88%567.08M	1,253.60%285.42M	13.65%114.28M	-66.52%345.18M	-75.17%175.63M	-96.65%21.09M	-79.86%100.55M	-76.02%1.03B	-77.08%707.4M	-69.45%629.79M
Cost of sales	----	87.68%-98.27M	----	-0.29%-1.22B	----	-154.31%-797.57M	----	6.17%-1.22B	----	49.85%-313.62M
Operating expenses	15.30%-146.28M	87.68%-98.27M	29.08%-46.23M	-0.29%-1.22B	28.54%-172.72M	-154.31%-797.57M	56.10%-65.19M	6.17%-1.22B	76.91%-241.69M	49.85%-313.62M
Gross profit	14,344.25%420.79M	124.10%187.15M	92.41%68.05M	-369.45%-876.02M	-99.37%2.91M	-345.59%-776.49M	-89.92%35.37M	-106.22%-186.61M	-77.16%465.71M	-77.98%316.17M
Selling expenses	-1.24%-196.04M	12.70%-112.48M	15.27%-46.59M	-32.55%-353.4M	-29.84%-193.63M	-44.93%-128.84M	-60.25%-54.98M	-151.95%-266.61M	-132.61%-149.14M	-157.07%-88.9M
Administrative expenses	37.57%-117.43M	37.33%-87.78M	38.78%-37.07M	-5.89%-294.45M	11.11%-188.09M	-0.30%-140.05M	5.54%-60.55M	-19.95%-278.07M	-49.97%-211.61M	-54.35%-139.63M
Research and development expenses	41.02%-272.27M	45.06%-185.9M	35.40%-96.75M	18.02%-637.99M	15.92%-461.67M	-4.45%-338.37M	4.70%-149.77M	11.43%-778.26M	16.27%-549.07M	41.23%-323.97M
Profit from asset sales	-163.08%-23.63K	----	----	----	--37.46K	----	----	----	----	----
Revaluation surplus	53.23%-7.19M	----	-129.16%-2.09M	----	-379.50%-15.37M	----	56.11%7.17M	----	-82.25%5.5M	----
-Changes in the fair value of other assets	53.23%-7.19M	----	-129.16%-2.09M	----	-379.50%-15.37M	----	56.11%7.17M	----	-82.25%5.5M	----
Impairment and provision	97.02%-23.9M	30.59%-14.06M	-16.94%-15.05M	-71.43%-15.05M	-50.46%-801.12M	-338.13%-20.26M	-108.88%-12.87M	-381.20%-8.78M	-11,281.90%-532.45M	-6,148.65%-4.62M
-Other impairment is provision	97.02%-23.9M	30.59%-14.06M	-16.94%-15.05M	-71.43%-15.05M	-50.46%-801.12M	-338.13%-20.26M	-108.88%-12.87M	-381.20%-8.78M	-11,281.90%-532.45M	-6,148.65%-4.62M
Special items of operating profit	-113.76%-23.02M	-160.73%-37.4M	-230.88%-66.79M	-5.26%141.72M	44.00%167.28M	-19.13%61.58M	31.82%51.03M	16.99%149.58M	204.12%116.16M	78.83%76.15M
Operating profit	84.89%-225.94M	81.34%-250.47M	-6.28%-198.26M	-48.69%-2.04B	-73.96%-1.5B	-714.58%-1.34B	-242.43%-186.54M	-171.60%-1.37B	-169.67%-859.78M	-120.54%-164.8M
Financing income	----	-38.87%54.09M	----	-46.75%120.64M	----	-36.10%88.49M	----	184.45%226.57M	----	235.72%138.49M
Financing cost	-96.12%3.11M	-11.65%-32.82M	502.46%23.38M	-53.82%-64.34M	-62.52%80.29M	-92.87%-29.4M	36.14%-5.81M	23.21%-41.83M	250.27%214.19M	-125.86%-15.24M
Special items of earning before tax	92.94%-2.87M	----	99.98%-1.72K	----	-3,128.89%-40.7M	----	-729.24%-8.12M	----	74.07%-1.26M	----
Earning before tax	84.50%-225.7M	82.14%-229.2M	12.76%-174.88M	-67.14%-1.98B	-125.10%-1.46B	-2,988.28%-1.28B	-265.82%-200.47M	-161.13%-1.18B	-150.13%-646.85M	-104.97%-41.56M
Tax	-228.18%-1.49M	-182.82%-964K	----	-94.78%11.45M	-99.26%1.16M	-97.98%1.16M	558.58%30.27M	838.17%219.24M	263.56%158.17M	-42.57%57.6M
After-tax profit from continuing operations	84.38%-227.2M	82.05%-230.16M	-2.75%-174.88M	-103.93%-1.97B	-197.72%-1.45B	-8,092.09%-1.28B	-248.91%-170.2M	-150.59%-964.76M	-136.64%-488.68M	-98.29%16.04M
Earning after tax	84.38%-227.2M	82.05%-230.16M	-2.75%-174.88M	-103.93%-1.97B	-197.72%-1.45B	-8,092.09%-1.28B	-248.91%-170.2M	-150.59%-964.76M	-136.64%-488.68M	-98.29%16.04M
Minority profit	98.98%-4.79M	98.91%-4.79M	84.38%-4.79M	-776.08%-484.7M	-3,192.65%-469.89M	-11,683.23%-440.74M	-330.62%-30.65M	-657.48%-55.33M	---14.27M	--3.81M
Profit attributable to shareholders	77.42%-222.41M	73.22%-225.37M	-21.89%-170.1M	-63.04%-1.48B	-107.63%-985.03M	-6,975.54%-841.43M	-214.94%-139.55M	-147.51%-909.43M	-135.57%-474.41M	-98.69%12.24M
Basic earnings per share	77.44%-0.9	73.31%-0.91	-21.05%-0.69	-63.32%-6.01	-107.81%-3.99	-6,988.89%-3.41	-216.33%-0.57	-147.55%-3.68	-135.62%-1.92	-98.69%0.0495
Diluted earnings per share	77.44%-0.9	73.31%-0.91	-21.05%-0.69	-63.32%-6.01	-107.81%-3.99	-6,988.89%-3.41	-216.33%-0.57	-147.55%-3.68	-135.62%-1.92	-98.69%0.0495
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	HKAS	CAS (2007)	HKAS	CAS (2007)	HKAS	CAS (2007)	HKAS	CAS (2007)	HKAS
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)	--	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks